FYN
FYN
FYN is a member of the Src family of non-receptor tyrosine kinases, which are involved in the regulation of various cellular processes. This protein plays a crucial role in the signaling pathways that control cell growth, differentiation, and survival. FYN is encoded by the FYN gene located on chromosome 6q21.
Structure[edit | edit source]
FYN is composed of several domains that are characteristic of Src family kinases. These include:
- SH3 domain: This domain is involved in protein-protein interactions and binds to proline-rich sequences in other proteins.
- SH2 domain: This domain binds to phosphorylated tyrosine residues, allowing FYN to interact with other phosphorylated proteins.
- Kinase domain: This is the catalytic domain responsible for the transfer of a phosphate group from ATP to a tyrosine residue on a substrate protein.
Function[edit | edit source]
FYN is involved in multiple cellular processes, including:
- T-cell receptor signaling: FYN is critical in the activation of T-cells, which are essential for the adaptive immune response.
- Neuronal development: FYN plays a role in the development and function of the nervous system, including axon guidance and synaptic plasticity.
- Cell adhesion and migration: FYN regulates the dynamics of the cytoskeleton, influencing cell shape and movement.
Clinical Significance[edit | edit source]
Mutations or dysregulation of FYN have been implicated in various diseases, such as:
- Cancer: Overexpression or hyperactivation of FYN has been observed in several types of cancer, including breast cancer and glioblastoma.
- Neurodegenerative diseases: Altered FYN activity has been associated with Alzheimer's disease and other neurodegenerative conditions.
Research[edit | edit source]
Ongoing research is focused on understanding the precise mechanisms by which FYN contributes to disease and exploring potential therapeutic targets. Inhibitors of FYN kinase activity are being investigated as potential treatments for cancer and other diseases.
Also see[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
